Funder | Trial | Period |
---|---|---|
Janssen | TMC207-C211 Phase II for Paediatric Bedaquiline |
2015 – 2024 |
University of Stellenbosch | TB CHAMP A phase III cluster RCT for preventive therapy for MDR-TB in children under 18 years |
2021 – 2023 |
MSF | TB-PRACTECAL Phase II-III for 6 months with Bedaquiline & Pretonamid |
2017 – 2022 |
USAID | STREAM STAGE 2 Phase III for 6-9 months with Bedaquiline |
2018 – 2021 |
TB Alliance | NC008 (SimplicitiTB) Phase IIC for 6-months with Bedaquiline & Pretonamid |
2018 – 2021 |
USAID | STREAM STAGE I Phase III for 9-months MDR-TB regimen |
2014 – 2018 |
TB Alliance | NC006 (STAND) Phase III for Pretonamid |
2014 – 2018 |
TB Alliance | NC005 Phase II for Pretonamid & Bedaqualine |
2014 – 2018 |
Otsuka | OPC67683 Phase III for Delamanid |
2013 – 2017 |
TB Alliance | NC002 Phase II for Pretonamid |
2012 – 2013 |
Clinical Trials Conductedadmin2023-02-21T12:18:11+02:00